PATENT CLAIM ANALYSIS

Application Number: 16207575
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["714", "001000"]

Abstract:
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotide molecules comprising an mRNA encoding an OX40L polypeptide. Also provided is a method for activating T cells or increasing the number of NK cells in a subject in need thereof.

Claim (Index 29):
The method of  claim 23 , wherein the mRNA comprises a 5\u2032 UTR comprising the nucleotide sequence as set forth in SEQ ID NO: 27, and a 3\u2032 UTR comprising the nucleotide sequence as set forth in SEQ ID NO: 63.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 98.0
- Lexical Diversity: 1.225
- Patent Class: 714.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15996140', '15995889', '16184282', '15996146', '16192274']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.4525608858092425
- 35 USC 102 Novelty (BERT): 0.6320243378214018
- Combined Prediction Score: 0.4705072310104585
- Mean Citation Score: 595.0456539999999
- Max Citation Score: 722.6448
- Similarity Product: 551.5146181835174

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test